Biotechnology company FIRN M was founded in 1989. Under leadership and supervision of the company's founder Professor Peter Gaponyuk the world’s first original interferon-based medicines have been developed, patented and produced – Grippferon®, Grippferon® with loratadine, Ophtalmoferon®, Herpferon®, Allergoferon®, Allergoferon® beta, Vagiferon®, Mycoferon® et al. FIRN M provides full-cycle high-tech contract manufacturing services for medicinal products complied with all GMP quality standards – from biological substances to ready-to-use dosage forms, including eye and nasal drops, sprays, suppositories, pre-filled syringes, ointments and gels. More information: www.firnm.ru